A novel flow cytometric assay to quantify soluble CD14 concentration in human serum

Cytometry

Volumn 45, Issue 2, 2001, Pages 115-123

  Antal Szalmás, Péter ^a   Szöllsi, Ibolya ^a,b   Lakos, Gabriella ^a,b   Kiss, Emese ^a,b   Csíp, István ^a   Sümegi, Andrea ^a,b   Sipka, Sándor ^a   Van Strijp, Jos A G ^a,b   Van Kessel, Kok P M ^a,b   Szegedi, Gyula ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Flow cytometry; Lipopolysaccharide; Soluble CD14; Systemic lupus erythematosus

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE BINDING PROTEIN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGENS, CD14; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MONOCYTES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0035477914     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0320(20011001)45:2<115::AID-CYTO1153>3.0.CO;2-M     Document Type: Article

References (37)

1. CD14: Cell surface receptor and differentiation marker
2. Evaluation of CD14 in host defence
3. Structure and function of lipopolysaccharide binding protein
4. Sepsis: A new hypothesis for pathogenesis of the disease process
5. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants
6. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14
7. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis
8. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus
9. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock
10. Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoid in vivo and in vitro
11. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome
12. Serum CD14 levels in polytraumatized and severely burned patients
13. CD14 expression and production by human hepatocytes
14. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14
15. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes
16. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14
17. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide
18. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes
19. Lipopolysaccharide induces apoptosis in a bovine endothelial cell line via a soluble CD14 dependent pathway
20. Functional role of endogenous CD14 in lipopolysaccharide-stimulated bone resorption
21. Lipopolysaccharide binding protein and soluble CD 14 catalyze exchange of phospholipids
22. Elevated levels of serum-soluble CD 14 in human immunodeficiency virus type 1 (HIV-1) infection: Correlation to disease progression and clinical events
23. Cerebrospinal fluid levels of soluble CD 14 in inflammatory and non-inflammatory diseases of the CNS: Upregulation during bacterial infections and viral meningitis
24. In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects
25. Soluble CD14 monocyte antigen in suction blister fluid and serum of patients with psoriasis
26. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis
27. Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis
28. CD14++ monocytes, CD14+/CD16+ subset and sCD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy
29. Comparison of seven immunoassays for the quantification of CA 125 antigen in serum
30. The meaning and use of the area under a receiver operating characteristic (ROC) curve
31. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
32. Quantitation of surface CD14 on human monocytes and neutrophils
33. Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes
34. Binding sites for endotoxins (lipopolysaccharides) on human monocytes
35. Systemic lupus erythematosus and related syndromes
36. Systemic lupus erythematosus survival in Hungary. Results from a single centre
37. Azurophilic granules of human neutrophils contain CD14